News

The Philadelphia Tribune18m
Prescription fluoride faces FDA scrutiny despite widespread support from providers and the public
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...
Infectious Disease Advisor3h
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research
The US FDA has appointed George Francis Tidmarsh, MD, PhD, as director of the Center for Drug Evaluation and Research.
Bristol Myers Squibb taps Cristian Massacesi as CMO
Bristol Myers Squibb (NYSE:BMY) has tapped Cristian Massacesi, as executive vice president, chief medical officer, and head of development, effective August 1, 2025. Massacesi most recently served as ...
Gilead wins EU backing for twice-yearly HIV PrEP therapy
Gilead (NASDAQ:GILD) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA) as ...
FDA’s Drug Chief Pick at Odds With RFK Jr.'s Revolving Door Vow
The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...
The New York Sun16h
EU Finds No Major Health Concerns With RFK Jr.’s Public Enemy No. 1 — Fluoride
The review notes that the current legal limit for drinking water in the bloc is 1.5 milligrams of fluoride per liter, which ...
MedPage Today20h
FDA 'Expert Panels' Raise Concerns of Evading Regulations, Ethics
Bypassing its standard pathways for scientific discussions, FDA has recently held a slew of so-called "expert panels" that ...
STAT22h
Safety of fluoride supplements, and freedom of choice, debated at FDA meeting
But it’s unclear if the evidence provided to support continued use of fluoridated supplements will matter. The FDA said in ...